MedPath

Samsung Medical Center

Samsung Medical Center logo
🇰🇷South Korea
Ownership
Subsidiary
Established
1994-01-01
Employees
501
Market Cap
-
Website
http://www.samsunghospital.com

Safety of 6-month Duration of Dual Antiplatelet Therapy After Acute Coronary Syndromes (SMART-DATE)

Not Applicable
Conditions
Acute Coronary Syndrome
Interventions
Drug: P2Y12 inhibitor (clopidogrel, ticagrelor, prasugrel)
First Posted Date
2012-10-05
Last Posted Date
2018-02-08
Lead Sponsor
Samsung Medical Center
Target Recruit Count
2712
Registration Number
NCT01701453
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Comparison of the Effects of Vecuronium and Cisatracurium on Electrophysiologic Monitoring During Neurosurgery

Not Applicable
Completed
Conditions
General Anesthesia
Spine Tumor
Neurosurgery
Cerebral Aneurysm
Motor Evoked Potential Monitoring
Brain Tumor
Interventions
Other: MEP monitoring with continuous infusion of cisatracurium during general anesthesia
Other: MEP monitoring with continuous infusion of vecuronium during general anesthesia
First Posted Date
2012-09-21
Last Posted Date
2013-12-25
Lead Sponsor
Samsung Medical Center
Target Recruit Count
74
Registration Number
NCT01690364
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Comparison Between Lidocaine, Dexmedetomidine, and Their Combined Infusion in Subjects Undergoing Coronary Artery Bypass Graft

Not Applicable
Completed
Conditions
Dexmedetomidine
Lidocaine
Myocardial Injury
Blood Electrolyte Balance
Coronary Artery Bypass Graft
Arrhythmia
Unstable Angina
Interventions
Drug: Lidocaine infusion
Drug: Dexmedetomidine infusion
First Posted Date
2012-09-20
Last Posted Date
2014-10-27
Lead Sponsor
Samsung Medical Center
Target Recruit Count
160
Registration Number
NCT01688648
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

A Long-term Observational Study on the Efficacy of SSRIs or Combined Treatment(SSRIs+ CBT) in Panic Disorder Patients

Conditions
Panic Disorder
First Posted Date
2012-08-29
Last Posted Date
2013-12-30
Lead Sponsor
Samsung Medical Center
Target Recruit Count
110
Registration Number
NCT01674673
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

Phase 4
Conditions
Variant Angina
Interventions
First Posted Date
2012-08-29
Last Posted Date
2018-02-09
Lead Sponsor
Samsung Medical Center
Target Recruit Count
200
Registration Number
NCT01674686
Locations
🇰🇷

Hyoen-Cheol Gwon, MD,PhD, Seoul, Korea, Republic of

Expression of TIM-3 and Correlation With Disease Activity in Pediatric Crohn's Disease With Anti TNF-α Therapy

Phase 3
Completed
Conditions
Crohn's Disease
Interventions
First Posted Date
2012-08-09
Last Posted Date
2012-08-09
Lead Sponsor
Samsung Medical Center
Target Recruit Count
20
Registration Number
NCT01661257
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Gemcitabine in NK/T Cell Lymphoma

Completed
Conditions
NK/T Cell Lymphoma
First Posted Date
2012-08-08
Last Posted Date
2013-02-13
Lead Sponsor
Samsung Medical Center
Target Recruit Count
20
Registration Number
NCT01660568
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Covered Versus Uncovered Self-expandable Metallic Stents for Malignant Gastric Outlet Obstruction

Phase 3
Completed
Conditions
Gastric Outlet Obstruction Due to Gastric Adenocarcinoma
Interventions
Device: Uncovered stent (Bona stent, pyloric/duodenal) insertion
Device: Covered stent (Bona stent pyloric/duodenal covered) insertion
First Posted Date
2012-07-20
Last Posted Date
2017-03-01
Lead Sponsor
Samsung Medical Center
Target Recruit Count
102
Registration Number
NCT01646476
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

The Effect of Remote Ischemic Postconditioning on Liver Graft and Renal Function in Patients Undergoing Living-related Liver Transplantation

Not Applicable
Completed
Conditions
Ischemia/Reperfusion Injury of Liver Graft
Ischemia/Reperfusion Injury of Kidney
Remote Ischemic Postconditioning
Interventions
Other: RIPC
First Posted Date
2012-07-10
Last Posted Date
2013-12-25
Lead Sponsor
Samsung Medical Center
Target Recruit Count
80
Registration Number
NCT01637038
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia

Active, not recruiting
Conditions
Bronchopulmonary Dysplasia
Interventions
Biological: Pneumostem®
First Posted Date
2012-07-03
Last Posted Date
2019-04-09
Lead Sponsor
Samsung Medical Center
Target Recruit Count
9
Registration Number
NCT01632475
Locations
🇰🇷

Samsung Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath